Milelli lab

Rimini-based Med Chem lab at UNIBO

[Milelli lab @Milellilab]

With @ElisaUliassi and @mlbolognesi we have illustrated how exploiting spatial proximity may represent a new frontier in the fight against #tauopathies. #acspharmacology&translationalscience
@ACSBioMed

https://t.co/9KeuOMINz8

[Elena Catanzaro @ElenaCatanzaro_]

Excited to share our latest research (and last I performed @Unibo) with @AndreaMilelli on the synthesis and antitumor potential of a novel rhodol-sulforaphane conjugate. Now published in the European Journal of Medicinal Chemistry @ElsevierConnect
https://t.co/oWMmdAO9FP

[Milelli lab @Milellilab]

📢 Our latest work on rhodol-sulforaphane conjugates characterized by a previously unreported mode of action is out! Check it out 🎯 @elenacatanzaro https://t.co/hkgerReBeo

[RSC Medicinal Chemistry @rsc_medchem]

🔓Check out the recent #OpenAccess work by @Milellilab, @mlbolognesi and colleagues regarding quinone-based HDACIs to cope with #Alzheimers and #cancer👇

https://t.co/Iq5JQHCSId

📍@unibo

[Milelli lab @Milellilab]

Nice to see our paper in the list 😊

RSC Medicinal Chemistry most downloaded articles in May 2024 https://t.co/rSYShp68aP

[Milelli lab @Milellilab]

📢Just come out in @ACSChemNeurosci our last paper on dual GSK-3β/HDACs inhibitors as a potential therapeutic to treat Alzheimer’s disease. @M4DatUNITO @desimone_angie @ChristianAOlsen @ACSBioMed https://t.co/mEVQpxDNIb

[Milelli lab @Milellilab]

🔔🎉 Now on @rsc_medchem our last work regarding quinone-based HDAC inhibitors to cope with Alzheimer's disease and cancer. Many thanks to @mlbolognesi @ElisaUliassi and all the collaborators 👇 https://t.co/HeuSYCDMWv

[Milelli lab @Milellilab]

🔔Check out our recent manuscript regarding polyamine-based MAO inhibitors as antiproliferative agents @Molecules_MDPI https://t.co/UQiKUfL62N

[Alessandra Salerno 👩‍🔬 @ales_salerno]

Proud to share the result of our journey into multi-functional #PROTACs.🥳That this reading might be of inspiration for enriching the #TPD field with new directions and modalities. Thanks to @mlbolognesi, @FraSeghetti & all the co-authors 👩‍🔬https://t.co/asLaDd8K5x

[ACS Publications Bio & Med Chem Content @ACSBioMed]

A different angle on multifunctional PROTACs: check out the new J Med Chem Perspective by @mlbolognesi & team from @Unibo on #PROTAC that is part of the New Drug Modalities Virtual Special Issue!

https://t.co/N6MwckGR6h

[Elisa Uliassi @ElisaUliassi]

Very proud to see our #OpenAccess perspective as one of the Most Read Articles in JMC @ACSBioMed @mlbolognesi @ales_salerno @FraSeghetti @JCaciolla @eleonoratesti @MarinellaRober1 @AndreaMilelli @Unibo https://t.co/eXhuEGymjJ

[ACS Publications Bio & Med Chem Content @ACSBioMed]

Targeted protein degradation for infectious diseases: from basic biology to drug discovery

A perspective from Andrea Milelli, Maria Laura Bolognesi et al @mlbolognesi @Unibo

🔓 Open access in ACS Bio & Med Chem Au 👉 https://t.co/Cb94CpsiLL